Volume 3 - Issue 3 - May/June 2006

Look around you. We are literally “surrounded” by innovation, less-invasive endovascular techniques and devices… “New paradigms” emerge every couple of years, perhaps more often! Many such new technologies and therapies can be classified as… | Read More

David E. Allie, MD, Chris J. Herbert, RT, RCIS, and Craig M. Walker, MD

Automated Contrast Injection and Targeted Renal Therapy: Strategies to Prevent Contrast-Induced Nephropathy and to Treat Renal Insufficiency It is currently estimated that in the United States there are 15–18 million patients with peripheral… | Read More

Kenneth Cavanaugh, Jr., PhD, •Lori Paserchia, MD, •Steve Phurrough, MD, MPA, Dorothy Abel, BS

Introduction As interventional technologies have evolved over the years, the use of intravascular stents to revascularize stenotic carotid arteries and reduce the incidence of stroke has been the topic of heated discussion within the clinical… | Read More

Jeffrey A. Goldstein, MD, Raghu Kolluri, MS, MD, Krishna Rocha-Singh, MD

Renal artery stenosis is the most common secondary cause of hypertension (HTN). It affects 5% of the 50 million people with HTN in the United States. Renovascular disease leads to malignant HTN in 10–45% of patients. In patients older than 50 years… | Read More

Hazim J. Safi, MD, Charles C. Miller, III, PhD, Anthony L. Estrera, MD, Ali Azizzadeh, MD

Thoracoabdominal aortic aneurysm (TAAA) repair is one of the most extensive operations undertaken by a surgeon. The size of the incision, as well as the number of organ systems that are at considerable risk during the procedure, places TAAA repair… | Read More

Nicolas W. Shammas, MD, MS

Introduction Peripheral vascular disease (PVD) is thrombogenic.1 There is a high frequency of elderly patients, diabetics, hyperlipidemics and smokers, conditions associated with hypercoagulation, in patients presenting with PVD. In addition,… | Read More

David E. Allie, MD

In this issue of VDM, Shammas has presented several algorithms regarding treatment of the spectrum of acute and chronic lower extremity ischemia with the emphasis refreshingly placed primarily on thrombus, platelets and “clot” management. I have… | Read More

Rex Liu, MD and Ashish Pershad, MD

Introduction The unique characteristics of the superficial femoral artery present challenges for revascularization. To safely and effectively treat this difficult multivariate disease state, a versatile treatment option is necessary. For a… | Read More

Michael Wholey, MD, MBA, •Boulos Toursarkissian, MD, Darren Postoak, MD, Raj Suri, MD, Marco Cura, MD, •Lisa Beal, RN

Introduction This case presents a patient scheduled to receive a femorofemoral bypass graft in conjunction with aortomonoiliac endograft. Initially, the patient was to undergo an endovascular stent graft repair for his abdominal aortic aneurysm and… | Read More